Response to Dr. Røe's comment letter

Affiliations

Comment

Martin C Tammemägi. Transl Lung Cancer Res. 2019 Apr.

. 2019 Apr;8(2):198-199.

doi: 10.21037/tlcr.2018.12.13.

¹ Department of Health Sciences, Brock University, Walker Complex-Academic South, St. Catharines, Ontario L2S 3A1, Canada.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Answer/comment to Prof. Tammemagi's article "Selecting lung cancer screenees using risk prediction models-where do we go from here".
Røe OD. Røe OD. Transl Lung Cancer Res. 2019 Apr;8(2):192-194. doi: 10.21037/tlcr.2018.10.09. Transl Lung Cancer Res. 2019. PMID: 31106130 Free PMC article. No abstract available.

1. Tammemagi MC, Church TR, Hocking WG, et al. Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts. PLoS Med 2014;11:e1001764. 10.1371/journal.pmed.1001764 - DOI - PMC - PubMed
1. Tammemagi M, Miller B, Yurcan M, et al. Determination of the Eligibility Criteria for Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk (Abstract #9432). American Thoracic Society International Conference; May 18-23, 2018; San Diego, 21 May 2018.
1. Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161-70. 10.1136/thoraxjnl-2015-207140 - DOI - PMC - PubMed
1. Malhotra J, Boffetta P, Mucci L. Cancer of the Lung, Larynx, and Pleura. In: Adami HO, Hunter D, Lagiou P, et al. editors. Textbook of Cancer Epidemiology, 3rd Edition. New York, USA: Oxford University Press, 2018.
1. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology 2017;284:228-43. 10.1148/radiol.2017161659 - DOI - PubMed